Revenue recognition model biotech collaboration

ASC 606 Revenue Recognition Model

If you are a biotech company with a strategic collaboration that is subject to ASC 606 revenue recognition, find out how easy it is to use our cost-to-cost, or input method, model. Our model calculates revenue and deferred revenue during the duration of the performance obligation. Let us handle the model calculations so you can focus your time and energy on getting model inputs right. 

Key Benefits

blurred-image-2.jpg

Data Integrity

Storing historical data in Excel is risky. Files can be changed or deleted accidentally, leaving you without the historical data. intheBlk locks and secures your data in the cloud.

blurred-image-2.jpg

Built for Biotech

An accounting tool does not require implementation or customization. intheBlk was built based on experience implementing ASC 606. Ready for immediate use with no extensive implementation needed.

blurred-image-2.jpg

Deeper Insights

Understand how changes to assumptions impact revenue recognition patterns. intheBlk provides deeper insights into understanding your revenue recognition patterns.

blurred-image-2.jpg

Export to Excel

An accounting tool does not require implementation or customization. intheBlk was built based on experience implementing ASC 606. Ready for immediate use with no extensive implementation needed.

blurred-image-2.jpg

Internal Controls

Controls get your auditors comfortable with your revenue recognition process. intheBlk provides an internal control log, user limitations and reviews documentation of assumptions used.

blurred-image-2.jpg

Consolidation

Tracking multiple performance obligations and collaborations in one Excel file is an error-prone task. intheBlk provides a dashboard with consolidated revenues for understanding the complete picture.

ASC 606 biotech collaboration agreement model